Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)
Clinical trial NCT01089088 · COMPLETED
Trial details
- NCT number
- NCT01089088
- Sponsor
- Cardiff University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2014-10-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.